Cargando…

Correlates of Coronary Artery Calcification Prevalence and Severity in Patients With Heterozygous Familial Hypercholesterolemia

BACKGROUND: Determinants of coronary artery calcification (CAC) prevalence and severity in heterozygous familial hypercholesterolemia (HeFH) remain understudied. The objective of this cross-sectional study was to investigate correlates of CAC in patients with HeFH. METHODS: A CAC score was calculate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Drouin-Chartier, Jean-Philippe, Tremblay, André J., Godbout, Dominic, Gagnon, Alexandre, Clavel, Marie-Annick, Clisson, Marine, Arsenault, Benoit J., Pibarot, Philippe, Larose, Éric, Couture, Patrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801218/ https://www.ncbi.nlm.nih.gov/pubmed/33458634 http://dx.doi.org/10.1016/j.cjco.2020.09.010

Ejemplares similares

Impact of Diet on Plasma Lipids in Individuals with Heterozygous Familial Hypercholesterolemia: A Systematic Review of Randomized Controlled Nutritional Studies
por: Roy, Gabrielle, et al.
Publicado: (2021)

The elevation of plasma concentrations of apoB-48-containing lipoproteins in familial hypercholesterolemia is independent of PCSK9 levels
por: Drouin-Chartier, Jean-Philippe, et al.
Publicado: (2017)

Comparison between cardiovascular magnetic resonance and transthoracic doppler echocardiography for the estimation of effective orifice area in aortic stenosis
por: Garcia, Julio, et al.
Publicado: (2011)

Progression of aortic stenosis after an acute myocardial infarction
por: Paquin, Amélie, et al.
Publicado: (2022)

Impact of dairy consumption on essential hypertension: a clinical study
por: Drouin-Chartier, Jean-Philippe, et al.
Publicado: (2014)

Determinants of Aortic Stenosis Progression in Bicuspid and Tricuspid Aortic Valves
por: Shen, Mylène, et al.
Publicado: (2022)

Plasma biomarkers of small intestine adaptations in obesity-related metabolic alterations
por: Lalande, Catherine, et al.
Publicado: (2020)

Aortic stenosis: what is the role of aging processes?
por: Côté, Nancy, et al.
Publicado: (2019)

Aortic Stenosis and Cardiac Amyloidosis: Watch Out for Traps!
por: Ternacle, Julien, et al.
Publicado: (2020)

Prevalence of left ventricle non-compaction criteria in adult patients with bicuspid aortic valve versus healthy control subjects
por: Shen, Mylène, et al.
Publicado: (2018)

Interaction of Autotaxin With Lipoprotein(a) in Patients With Calcific Aortic Valve Stenosis
por: Bourgeois, Raphaëlle, et al.
Publicado: (2020)

Relations of physical signs to genotype, lipid and inflammatory markers, coronary stenosis or calcification, and outcomes in patients with heterozygous familial hypercholesterolemia
por: Liu, Ming-Ming, et al.
Publicado: (2021)

Accuracy of stroke volume measurement with phase-contrast cardiovascular magnetic resonance in patients with aortic stenosis
por: Guzzetti, Ezequiel, et al.
Publicado: (2021)

Dobutamine Stress Echocardiography in Low‐Flow, Low‐Gradient Aortic Stenosis: Flow Reserve Does Not Matter Anymore
por: Annabi, Mohamed‐Salah, et al.
Publicado: (2019)

Diagnosis and Treatment of Heterozygous Familial Hypercholesterolemia
por: McGowan, Mary P., et al.
Publicado: (2019)

Multimodality Imaging for Discordant Low-Gradient Aortic Stenosis: Assessing the Valve and the Myocardium
por: Guzzetti, Ezequiel, et al.
Publicado: (2020)

ApoB/ApoA‐I Ratio is Associated With Faster Hemodynamic Progression of Aortic Stenosis: Results From the PROGRESSA (Metabolic Determinants of the Progression of Aortic Stenosis) Study
por: Tastet, Lionel, et al.
Publicado: (2018)

Genetic screening for homozygous and heterozygous familial hypercholesterolemia
por: Izar, Maria C, et al.
Publicado: (2010)

Impact of Vascular Hemodynamics on Aortic Stenosis Evaluation: New Insights Into the Pathophysiology of Normal Flow—Small Aortic Valve Area—Low Gradient Pattern
por: Côté, Nancy, et al.
Publicado: (2017)

Timing of intervention in aortic stenosis: a review of current and future strategies
por: Everett, Russell James, et al.
Publicado: (2018)

A transcriptome-wide association study identifies PALMD as a susceptibility gene for calcific aortic valve stenosis
por: Thériault, Sébastien, et al.
Publicado: (2018)

Carotid and Aortic Stiffness in Patients with Heterozygous Familial Hypercholesterolemia
por: Ershova, Alexandra I., et al.
Publicado: (2016)

Myocardial fibrosis assessed by magnetic resonance imaging in asymptomatic heterozygous familial hypercholesterolemia: the cholcoeur study
por: Gallo, Antonio, et al.
Publicado: (2021)

Coronary lesion complexity in patients with heterozygous familial hypercholesterolemia hospitalized for acute myocardial infarction: data from the RICO survey
por: Yao, Hermann, et al.
Publicado: (2021)

Impact of milk consumption on cardiometabolic risk in postmenopausal women with abdominal obesity
por: Drouin-Chartier, Jean-Philippe, et al.
Publicado: (2015)

Genetic and In Vitro Inhibition of PCSK9 and Calcific Aortic Valve Stenosis
por: Perrot, Nicolas, et al.
Publicado: (2020)

Optimized Treatment of Refractory Hypercholesterolemia in Patients With Atherosclerotic Cardiovascular Disease or Heterozygous Familial Hypercholesterolemia With Alirocumab (OPTIMIZE)
por: Sudano, Isabella, et al.
Publicado: (2022)

Role of colesevelam in managing heterozygous familial hypercholesterolemia in adolescents and children
por: Sonnett, Travis, et al.
Publicado: (2010)

Bempedoic Acid for Heterozygous Familial Hypercholesterolemia: From Bench to Bedside
por: Agarwala, Anandita, et al.
Publicado: (2021)

Awareness and knowledge of heterozygous familial hypercholesterolemia among Serbian pediatricians
por: Bjelakovic, Ljiljana, et al.
Publicado: (2023)

Impact of Age on the Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia
por: Ginsberg, Henry N., et al.
Publicado: (2019)

Prevalent Coronary Artery Disease and Undertreatment in Heterozygous Familial Hypercholesterolemia -Real-World Data and “Heterozygous FH Score” from FAME Study-
por: Nohara, Atsushi
Publicado: (2022)

Burden of cardiovascular disease in a large contemporary cohort of patients with heterozygous familial hypercholesterolemia
por: Ferrières, Jean, et al.
Publicado: (2022)

Cascade Screening and Treatment Initiation in Young Adults with Heterozygous Familial Hypercholesterolemia
por: Peterson, Amy L., et al.
Publicado: (2021)

Sex-dependent alterations in the physiology of entorhinal cortex neurons in old heterozygous 3xTg-AD mice
por: Arsenault, Dany, et al.
Publicado: (2020)

Temporal trends of aortic stenosis and comorbid chronic kidney disease in the province of Quebec, Canada
por: Khelifi, Nada, et al.
Publicado: (2022)

Cataract Surgery in Elderly Subjects with Heterozygous Familial Hypercholesterolemia in Prolonged Treatment with Statins
por: Marco-Benedí, Victoria, et al.
Publicado: (2021)

How Can We Identify Very High-Risk Heterozygous Familial Hypercholesterolemia?
por: Kataoka, Yu, et al.
Publicado: (2022)

Relationship Between QT Interval and Outcome in Low‐Flow Low‐Gradient Aortic Stenosis With Low Left Ventricular Ejection Fraction
por: Dahou, Abdellaziz, et al.
Publicado: (2016)

Mid-term clinical and echocardiographic results of the INSPIRIS RESILIA aortic valve: a retrospective comparison to the Magna Ease
por: Bernard, Jérémy, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ll13qj178j2ekig9tdqgddt5ue